VTV THERAPEUTICS INC- CL A (VTVT) Stock Analyst Earnings Estimates
NASDAQ:VTVT - Nasdaq - US9183852048 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.41M 132.25% | 4.01M -37.44% | 2.02M -49.63% | -100.00% | 1.02M | -100.00% | ||
| EBITDA YoY % growth | -11.76M 43.60% | -19.97M -69.81% | -22.45M -12.42% | N/A -13.19% | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.85M 43.27% | -20.06M -69.28% | -22.54M -12.36% | -44.794M -13.14% | -26.406M -3.54% | -38.913M -47.37% | -54.264M -39.45% | |
| Operating Margin | -184.87% | -500.25% | -1,115.84% | N/A | -2,588.80% | N/A | N/A | |
| EPS YoY % growth | -0.19 98.97% | -0.22 -15.79% | -4.54 -1,963.64% | -0.38 91.69% | -3.72 -886.49% | -4.95 -32.88% | -5.20 -5.15% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.89 -728.57% | -1.12 4.10% | -1.38 -1,587.50% | -1.18 -1,188.89% | -1.26 -42.53% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.256M -139.13% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -1.17 51.25% | -0.08 | -1.09 | -1,333.82% |
| Q4 2023 Q2Q % growth | 95.54% | -0.11 | % | |
| Q3 2023 Q2Q % growth | -0.08 96.00% | -0.11 | 0.03 | 25.30% |
| Q2 2023 Q2Q % growth | -104.00% | -0.08 | % | |
| Q1 2023 Q2Q % growth | -2.40 -2,300.00% | -3.88 | 1.48 | 38.08% |
| Q4 2022 Q2Q % growth | -2.40 -2,081.82% | -2.58 | 0.18 | 7.12% |
| Q3 2022 Q2Q % growth | -2.00 -9,900.00% | -1.77 | -0.23 | -13.13% |
| Q2 2022 Q2Q % growth | -0.04 -300.00% | -0.09 | 0.05 | 56.43% |
| Q1 2022 Q2Q % growth | -0.10 -25.00% | -0.08 | -0.02 | -22.55% |
| Q4 2021 Q2Q % growth | -0.11 -650.00% | -0.08 | -0.03 | -43.79% |
| Q3 2021 Q2Q % growth | -0.02 33.33% | -0.07 | 0.05 | 71.99% |
| Q2 2021 Q2Q % growth | -0.01 85.71% | -0.07 | 0.06 | 85.99% |
| Q1 2021 Q2Q % growth | -0.08 27.27% | -0.06 | -0.02 | -30.72% |
| Q4 2020 Q2Q % growth | 0.02 115.38% | -0.06 | 0.08 | 135.65% |
| Q3 2020 Q2Q % growth | -0.03 76.92% | -0.10 | 0.07 | 69.04% |
| Q2 2020 Q2Q % growth | -0.07 30.00% | -0.10 | 0.03 | 27.76% |
| Q4 2019 Q2Q % growth | -0.13 | -0.10 | -0.03 | -34.16% |
| Q3 2019 Q2Q % growth | -0.13 | -0.11 | -0.02 | -15.86% |
| Q2 2019 Q2Q % growth | -0.10 | -0.11 | 0.01 | 6.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 10K | 10K | % | |
| Q3 2022 Q2Q % growth | -100.00% | 255K | -255K | -100.00% |
| Q2 2022 Q2Q % growth | 10K | 10K | % | |
| Q1 2022 Q2Q % growth | 2M 102.02% | 2M | % | |
| Q4 2021 Q2Q % growth | 10K -99.84% | 1.02M | -1.01M | -99.02% |
| Q3 2021 Q2Q % growth | 3M 29,900.00% | 1.326M | 1.674M | 126.24% |
| Q2 2021 Q2Q % growth | 10K | 1.02M | -1.01M | -99.02% |
| Q1 2021 Q2Q % growth | 990K 9,800.00% | 816K | 174K | 21.32% |
| Q4 2020 Q2Q % growth | 6.4M 63,900.00% | 1.683M | 4.717M | 280.27% |
| Q3 2020 Q2Q % growth | 10K | 10K | % | |
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | 10K -98.91% | 10K | % | |
| Q4 2019 Q2Q % growth | 10K | 2.55M | -2.54M | -99.61% |
| Q3 2019 Q2Q % growth | 10K | 1.721M | -1.711M | -99.42% |
| Q2 2019 Q2Q % growth | 1.83M | 1.658M | 172K | 10.37% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -987.5% | -987.5% | 0% | -1006.06% |
| Revenue | N/A | N/A | 0% | N/A |